Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

Recent & Breaking News (CSE:PILL)

Canntab Announces Non-Brokered Private Placement

Canada NewsWire February 6, 2020

Canntab Submits Site Evidence Package to Health Canada to Obtain LP Status

Canada NewsWire December 23, 2019

IIROC Trade Resumption - PILL

Canada NewsWire November 20, 2019

Exactus, Inc. Enters into Supply & Distribution Agreement with Canntab Therapeutics to Produce Immediate and Extended Release Tablets

GlobeNewswire November 20, 2019

Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

Canada NewsWire November 20, 2019

IIROC Trading Halt - PILL

Canada NewsWire November 20, 2019

Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities

Canada NewsWire October 8, 2019

InvestmentPitch Media Video Discusses Canntab's Receipt of Initial Indication of Patentability for Immediate Release Cannabidiol Formulation - Video Available on Investmentpitch.com

Newsfile August 16, 2019

Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation

PR Newswire August 15, 2019

InvestmentPitch Media Video Discusses Canntab's Update of Significant Developments Including Hemp Cultivation and Gel Capsule Manufacturing - Video Available on Investmentpitch.com

Newsfile August 1, 2019

Canntab provides corporate update

Canada NewsWire July 31, 2019

Marijuana Investor Magazine June/July 2019 Issue Now Available

Accesswire June 24, 2019

Canntab Therapeutics Featured in the Canadian Cannabis Investor Magazine

Accesswire June 24, 2019

InvestmentPitch Media Video Discusses Canntab's Term Sheet with Heritage Cannabis to Process Hemp into High Quality CBD Oil for Canntab's Gelcaps - Video Available on Investmentpitch.com

Newsfile May 31, 2019

Canntab Signs Term Sheet with Heritage for Processing Hemp for Sale of CBD Filled Gelcaps

Business Wire May 30, 2019

Canntab signs term sheet with Heritage for processing hemp for sale of CBD filled gelcaps

Canada NewsWire May 30, 2019

InvestmentPitch Media Video Discusses Canntab's Receipt of Cultivation Licence from Health Canada to Grow Industrial Hemp - Video Available on Investmentpitch.com

Newsfile May 22, 2019

Canntab Receives Cultivation Licence for Industrial Hemp

Canada NewsWire May 21, 2019

Canntab Therapeutics Now Trading on the OTCQX Best Market

Canada NewsWire May 1, 2019

OTC Markets Group Welcomes Canntab Therapeutics Ltd to OTCQX

PR Newswire May 1, 2019